Company Encyclopedia
View More
name
Modular Medical
MODD.US
Modular Medical, Inc. operates as a medical device company. The company focuses on the design, development, and commercialization of insulin pumps. It also offers MODD1, a two-part patch pump for type-1 and type-2 diabetes.
1.407 T
MODD.USMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    MODD, LAB, HOWL, COGT, LGVN, ABCL Lead Biotech After-Hours Rally - Nov 26

    Several biotech companies, including Modular Medical, Standard BioTools, Werewolf Therapeutics, Cogent Biosciences, Longeveron, and AbCellera Biologics, saw notable gains in after-hours trading on November 26. Despite a quiet news cycle, investor interest remained strong, with Modular Medical's shares surging 11.51% following recent IRB approval for its Pivot insulin delivery system study. Other companies also experienced gains, reflecting investor confidence in their respective projects and collaborations.

    rttnews·
    US
    HOWL
    +8.54%
    US
    ABCL
    +4.58%
    US
    MODD
    +7.10%
    rttnews·
    US
    HOWL
    +8.54%
    US
    ABCL
    +4.58%
    US
    MODD
    +7.10%

    Modular Medical Secures IRB Approval for Pivot Insulin Pump Study

    Modular Medical Inc. has received IRB approval to conduct an in-house study of its Pivot™ insulin delivery system. The study aims to simulate real-world conditions and gather data on device function, usability, and participant feedback. This approval is a key milestone as the company awaits FDA clearance for the Pivot system.

    Reuters·
    US
    MODD
    +7.10%
    Reuters·
    US
    MODD
    +7.10%

    Modular Medical Submits Pivot Tubeless Insulin Patch Pump for FDA 510(k) Clearance

    Modular Medical has submitted its Pivot tubeless insulin patch pump for FDA 510(k) clearance, targeting a $3 billion market. The Pivot pump, featuring a 3 ml removable reservoir and no need for a controller, aims to simplify diabetes management. The company plans a Q1 2026 launch, pending FDA approval. Submission was delayed by a U.S. government shutdown, with initial FDA questions expected in Q4 2025. The Pivot system is not yet FDA-cleared for sale.

    Acceswire·
    US
    MODD
    +7.10%
    Acceswire·
    US
    MODD
    +7.10%

    Modular Medical Announces Ongoing Progress to Obtain CE Mark

    Modular Medical, Inc. is progressing towards CE Mark certification under EU MDR 2017/745, with a successful Stage 1 ISO 13485:2016 audit completed. The company plans to advance to Stage 2 audit in early 2026, which is crucial for achieving ISO certification. Preparations for CE technical documentation review are expected to start later in 2026, aiming for a commercial launch in the EU. The Pivot insulin delivery system is not yet cleared for sale in the U.S. or other markets. Forward-looking statements highlight potential risks and uncertainties in achieving these goals.

    Acceswire·
    US
    MODD
    +7.10%
    Acceswire·
    US
    MODD
    +7.10%

    Modular Medical Appoints David Bosshard to Lead International Expansion of Pivot Insulin Delivery System

    Modular Medical Inc. has appointed David Bosshard as Head of International Operations to spearhead the global expansion of its Pivot insulin delivery system. Bosshard brings significant experience in launching insulin delivery systems worldwide. This announcement was published via ACCESS Newswire on October 06, 2025.

    Reuters·
    US
    MODD
    +7.10%
    Reuters·
    US
    MODD
    +7.10%
    © 2025 Longbridge｜Disclaimer